Who owns 004225908 - ACADIA PHARMACEUTICALS INC - CALL based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

ACADIA PHARMACEUTICALS INC - CALL Institutional Ownership

CUSIP 004225908 is the security identifier used in SEC filing datasets for 004225908 - ACADIA PHARMACEUTICALS INC - CALL.

CUSIP: 004225908

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

What is CUSIP 004225908?
CUSIP 004225908 identifies 004225908 - ACADIA PHARMACEUTICALS INC - CALL in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Open recent reporting periods for CUSIP 004225908:

As of 31 Dec 2025, 0 institutional investors reported holding shares of ACADIA PHARMACEUTICALS INC - CALL.

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Calls Notional Value	Price (Median)	Investors
2025 Q4				$381,953	$26.71	0
2025 Q3				$2,890,589	$21.34	0
2025 Q2				$2,370,025	$21.57	0
2025 Q1				$913,149	$16.60	0
2024 Q4				$2,718,905	$18.34	0
2024 Q3				$2,160,144	$15.38	0
2024 Q2				$1,719,250	$16.25	0
2024 Q1				$4,633,945	$18.49	0
2023 Q4				$12,673,892	$31.31	0
2023 Q3				$12,197,172	$20.84	0
2023 Q2				$7,584,760	$23.95	0
2023 Q1				$6,439,480	$18.82	0
2022 Q4				$5,878,616	$15.92	0
2022 Q3				$5,813,000	$16.36	0
2022 Q2				$8,417,000	$14.09	0
2022 Q1				$11,354,000	$24.22	0
2021 Q4				$16,823,000	$23.34	0
2021 Q3				$2,161,000	$20.69	0
2021 Q2				$6,338,000	$24.39	0
2021 Q1				$3,287,000	$25.81	0
2020 Q4				$10,761,000	$53.44	0
2020 Q3				$7,371,000	$41.25	0
2020 Q2				$10,741,000	$48.47	0
2020 Q1	0	$0	-$3,124,000	$9,531,000	$4223.08	0
2019 Q4	180,600	$3,124,000	+$3,124,000	$16,350,000	$42.78	1
2019 Q3				$13,708,000	$35.99	0
2019 Q2				$4,394,000	$1348.94	0
2019 Q1				$8,404,000	$1355.09	0
2018 Q4				$5,435,000	$816.52	0
2018 Q3				$9,240,000	$20.76	0
2018 Q2				$3,426,000	$769.73	0
2018 Q1				$2,877,000	$75.09	0
2017 Q4				$6,537,000	$107.36	0
2017 Q3				$6,682,000	$233.34	0
2017 Q2				$7,725,000	$52.41	0
2017 Q1				$10,565,000	$93.43	0
2016 Q4				$27,677,000	$123.79	0
2016 Q3				$6,465,000	$75.04	0
2016 Q2				$25,542,000	$97.75	0
2016 Q1				$26,050,000	$182.27	0
2015 Q4				$23,628,000	$412.35	0
2015 Q3				$11,714,000	$318.18	0
2015 Q2				$17,149,000	$797.54	0
2015 Q1				$14,742,000	$32.59	0
2014 Q4				$106,208,000	$617.50	0
2014 Q3				$12,417,000	$24.76	0
2014 Q2				$71,731,000	$22.59	0
2014 Q1				$80,145,000	$24.33	0